Drug Shortage Report for CORTIFOAM
| Report ID | 56188 |
| Drug Identification Number | 00579335 |
| Brand name | CORTIFOAM |
| Common or Proper name | CORTIFOAM |
| Company Name | PALADIN LABS INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROCORTISONE ACETATE |
| Strength(s) | 10% |
| Dosage form(s) | AEROSOL, FOAM |
| Route of administration | RECTAL |
| Packaging size | 15g |
| ATC code | A07EA |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-07-23 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-06-17 |
| Company comments | Longterm Backorder |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-07-23 | English | Compare |
| v2 | 2018-07-23 | French | Compare |
| v3 | 2018-07-24 | English | Compare |
| v4 | 2019-04-01 | English | Compare |
| v5 | 2019-04-01 | French | Compare |
Showing 1 to 5 of 5